These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12810647)

  • 1. Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.
    Ng SS; Gütschow M; Weiss M; Hauschildt S; Teubert U; Hecker TK; Luzzio FA; Kruger EA; Eger K; Figg WD
    Cancer Res; 2003 Jun; 63(12):3189-94. PubMed ID: 12810647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide metabolites and analogues. 3. Synthesis and antiangiogenic activity of the teratogenic and TNFalpha-modulatory thalidomide analogue 2-(2,6-dioxopiperidine-3-yl)phthalimidine.
    Luzzio FA; Mayorov AV; Ng SS; Kruger EA; Figg WD
    J Med Chem; 2003 Aug; 46(18):3793-9. PubMed ID: 12930142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Petasiphenol which inhibits DNA polymerase lambda activity is an inhibitor of in vitro angiogenesis.
    Matsubara K; Mori M; Mizushina Y
    Oncol Rep; 2004 Feb; 11(2):447-51. PubMed ID: 14719082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors.
    Lepper ER; Ng SS; Gütschow M; Weiss M; Hauschildt S; Hecker TK; Luzzio FA; Eger K; Figg WD
    J Med Chem; 2004 Apr; 47(9):2219-27. PubMed ID: 15084120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic activity of nasunin, an antioxidant anthocyanin, in eggplant peels.
    Matsubara K; Kaneyuki T; Miyake T; Mori M
    J Agric Food Chem; 2005 Aug; 53(16):6272-5. PubMed ID: 16076105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
    Ng SS; MacPherson GR; Gütschow M; Eger K; Figg WD
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4192-7. PubMed ID: 15217957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitors derived from thalidomide.
    Noguchi T; Fujimoto H; Sano H; Miyajima A; Miyachi H; Hashimoto Y
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5509-13. PubMed ID: 16183272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer.
    Capitosti SM; Hansen TP; Brown ML
    Bioorg Med Chem; 2004 Jan; 12(2):327-36. PubMed ID: 14723953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues.
    Beedie SL; Peer CJ; Pisle S; Gardner ER; Mahony C; Barnett S; Ambrozak A; Gütschow M; Chau CH; Vargesson N; Figg WD
    Mol Cancer Ther; 2015 Oct; 14(10):2228-37. PubMed ID: 26269604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition.
    Gee MS; Makonnen S; al-Kofahi K; Roysam B; Payvandi F; Man HW; Muller GW; Lee WM
    Cancer Res; 2003 Dec; 63(23):8073-8. PubMed ID: 14678955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.
    Haviv F; Bradley MF; Kalvin DM; Schneider AJ; Davidson DJ; Majest SM; McKay LM; Haskell CJ; Bell RL; Nguyen B; Marsh KC; Surber BW; Uchic JT; Ferrero J; Wang YC; Leal J; Record RD; Hodde J; Badylak SF; Lesniewski RR; Henkin J
    J Med Chem; 2005 Apr; 48(8):2838-46. PubMed ID: 15828822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the antiangiogenic potential of AQ4N.
    O'Rourke M; Ward C; Worthington J; McKenna J; Valentine A; Robson T; Hirst DG; McKeown SR
    Clin Cancer Res; 2008 Mar; 14(5):1502-9. PubMed ID: 18316575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs.
    El-Aarag BY; Kasai T; Zahran MA; Zakhary NI; Shigehiro T; Sekhar SC; Agwa HS; Mizutani A; Murakami H; Kakuta H; Seno M
    Int Immunopharmacol; 2014 Aug; 21(2):283-92. PubMed ID: 24859059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells.
    Komorowski J; Jerczyńska H; Siejka A; Barańska P; Ławnicka H; Pawłowska Z; Stepień H
    Life Sci; 2006 Apr; 78(22):2558-63. PubMed ID: 16310808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.
    Lentzsch S; Rogers MS; LeBlanc R; Birsner AE; Shah JH; Treston AM; Anderson KC; D'Amato RJ
    Cancer Res; 2002 Apr; 62(8):2300-5. PubMed ID: 11956087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
    Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
    Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary biological evaluations of new thalidomide analogues for multiple sclerosis application.
    Contino-Pépin C; Parat A; Périno S; Lenoir C; Vidal M; Galons H; Karlik S; Pucci B
    Bioorg Med Chem Lett; 2009 Feb; 19(3):878-81. PubMed ID: 19103485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel quantitative chick embryo assay as an angiogenesis model using digital image analysis.
    Peifer C; Dannhardt G
    Anticancer Res; 2004; 24(3a):1545-51. PubMed ID: 15274321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis.
    Du GJ; Lin HH; Xu QT; Wang MW
    Vascul Pharmacol; 2005 Aug; 43(2):112-9. PubMed ID: 15982930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.